In response to member company concerns about the regulatory interpretation of recent laws and regulations over the past six months, the US-China Business Council (USCBC) continues its advocacy initiatives and its operating environment analyses and best practices for member companies in the United States and China.
China Market Intelligence
A series of recent hospital reforms by the Chinese government are designed to standardize pricing and encourage investment in the medical system.
Four new policies under development may address a variety of lingering regulatory hurdles for foreign drug and device companies in China.
As China aims to expand nationwide health insurance, improve patient access to care, strengthen primary care, and deepen investment in rural regions, US companies want in on the